Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines

Background: Treatment of malignancies is still a major challenge in human and canine cancer, mostly due to the emergence of multidrug resistance (MDR). One of the main contributors of MDR is the overexpression P-glycoprotein (Pgp), which recognizes and extrudes various chemotherapeutics from cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Karai, Edina, Szebényi, Kornélia, Windt, Tímea, Fehér, Sára, Szendi, Eszter, Dékay, Valéria, Vajdovich, Péter, Szakács, Gergely, Füredi, András
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280963/
https://www.ncbi.nlm.nih.gov/pubmed/32365663
http://dx.doi.org/10.3390/cancers12051117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280963/
https://www.ncbi.nlm.nih.gov/pubmed/32365663
http://dx.doi.org/10.3390/cancers12051117

Ejemplares similares